Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SCM-004 1/30/03 2/12/03 DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-002 7/8/02 7/9/02 Definity, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-001 2/21/02 2/21/02 Definity (perflutren Lipid Microsphere) Injectable Suspension, DuPont Company NDA 21-064 7/31/01 05/08/03 11/1/01 Definity Indications: Use of activated Definity (perflutren Lipid Microsphere) Injectable Suspension in patients with suboptimal echocardiograms to opacity the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. | DEFINITY (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb, Labeling Revision | Optison (Perflutren Protein-Type A Micropheres) Injection, GE Healthcare, Labeling Revision | Definity (perflutren) Injection, Lantheus Medical Imaging, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com